[Prophylaxis and treatment of infectious complications in burns (author's transl)].
To lower infectious complications and the mortality rate due to septicaemia in burned patients more knowledge should be acquired to increase the natural resistance of the organism of the burned. This can be done by administering Staphylococcal-Anatoxin, Antistaphylococcal-Plasma, Antipyocyaneus-Serum and convalescent-Serum.
D000917:Antibody Formation / Q000187:drug effects; D002056:Burns / Q000150:complications*; D006801:Humans; D007106:Immune Sera; D007114:Immunization; D007962:Leukocytes / Q000276:immunology; D009113:Muramidase / Q000627:therapeutic use; D010587:Phagocytosis / Q000187:drug effects; D011354:Prodigiozan / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000517:prevention & control; D014946:Wound Infection / Q000276:immunology*
D007106:Immune Sera; D011354:Prodigiozan; D009113:Muramidase
Die Anwendung von Immunpräparaten zur Prophylaxe und Therapie infektiöser Komplikationen bei Verbrennungen.